MCID: RTC009
MIFTS: 52

Reticulum Cell Sarcoma

Categories: Blood diseases, Rare diseases, Cancer diseases

Aliases & Classifications for Reticulum Cell Sarcoma

MalaCards integrated aliases for Reticulum Cell Sarcoma:

Name: Reticulum Cell Sarcoma 57 59
Dendritic Cell Sarcoma, Interdigitating 73
Interdigitating Dendritic Cell Sarcoma 59
Interdigitating Cell Sarcoma 59
Reticulosarcoma 73

Characteristics:

Orphanet epidemiological data:

59

OMIM:

57
Inheritance:
autosomal recessive in several families


Classifications:



External Ids:

OMIM 57 267730
Orphanet 59 ORPHA86900
UMLS via Orphanet 74 C1260326 C0024302
MESH via Orphanet 45 D054739
ICD10 via Orphanet 34 C96.4
MedGen 42 C0024302

Summaries for Reticulum Cell Sarcoma

MalaCards based summary : Reticulum Cell Sarcoma, also known as dendritic cell sarcoma, interdigitating, is related to interdigitating dendritic cell sarcoma and follicular dendritic cell sarcoma, and has symptoms including fatigue, fever and night sweats. An important gene associated with Reticulum Cell Sarcoma is VIM (Vimentin), and among its related pathways/superpathways are Innate Immune System and Cytoskeletal Signaling. The drugs Cisplatin and Cyclophosphamide have been mentioned in the context of this disorder. Affiliated tissues include b cells, bone and bone marrow, and related phenotypes are sarcoma and cellular

Description from OMIM: 267730

Related Diseases for Reticulum Cell Sarcoma

Diseases related to Reticulum Cell Sarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 163)
# Related Disease Score Top Affiliating Genes
1 interdigitating dendritic cell sarcoma 34.3 CR1 CR2 PTPRC
2 follicular dendritic cell sarcoma 29.8 CR1 CR2 FCER2
3 reticulosarcoma 29.8 MUC1 PTPRC TNFRSF8
4 multicentric reticulohistiocytosis 10.8 PTPRC VIM
5 retroperitoneal fibrosis 10.8 PTPRC VIM
6 malignant peritoneal mesothelioma 10.8 MUC1 VIM
7 fibrous meningioma 10.8 MUC1 VIM
8 infantile digital fibromatosis 10.8 DES VIM
9 chordoid meningioma 10.8 MUC1 VIM
10 malignant mixed mullerian tumor 10.8 MUC1 VIM
11 nodular hidradenoma 10.8 MUC1 VIM
12 eccrine porocarcinoma 10.8 MUC1 VIM
13 lymphangiomatosis 10.8 DES VIM
14 primary cutaneous anaplastic large cell lymphoma 10.8 MUC1 PTPRC
15 malignant ectomesenchymoma 10.8 DES S100A1
16 endometrial mucinous adenocarcinoma 10.8 MUC1 VIM
17 myxopapillary ependymoma 10.8 MUC1 VIM
18 monophasic synovial sarcoma 10.8 MUC1 VIM
19 epulis 10.7 DES VIM
20 spiradenoma 10.7 MUC1 VIM
21 spindle cell thymoma 10.7 DES MUC1
22 liver inflammatory pseudotumor 10.7 CR2 PTPRC
23 hidradenoma 10.7 MUC1 VIM
24 extracutaneous mastocytoma 10.7 CD2 PTPRC
25 spindle cell rhabdomyosarcoma 10.7 DES MUC1
26 ovarian small cell carcinoma 10.7 DES MUC1
27 anaplastic ependymoma 10.7 MUC1 VIM
28 sertoli cell tumor 10.6 MUC1 VIM
29 papillary tumor of the pineal region 10.6 MUC1 S100A1 VIM
30 ovarian lymphoma 10.6 CR2 PTPRC
31 juvenile xanthogranuloma 10.6 DES VIM
32 chondroid chordoma 10.6 MUC1 S100A1 VIM
33 perineurioma 10.6 MUC1 VIM
34 pericardial mesothelioma 10.6 MUC1 S100A1 VIM
35 dermoid cyst 10.6 MUC1 VIM
36 lymphangiectasis 10.6 ACTC1 VIM
37 mucinous cystadenocarcinoma 10.6 MUC1 PTPRC VIM
38 sarcoma 10.6
39 glomangiomyoma 10.6 ACTC1 VIM
40 proximal spinal muscular atrophy 10.6 DES MUC1
41 intravascular papillary endothelial hyperplasia 10.6 ACTC1 VIM
42 polyclonal hypergammaglobulinemia 10.6 CD2 CD4
43 nodular tenosynovitis 10.6 PTPRC S100A9
44 primitive neuroectodermal tumor of the cervix uteri 10.5 DES PTPRC VIM
45 malignant giant cell tumor of soft parts 10.5 ACTC1 PTPRC
46 parapharyngeal meningioma 10.5 CR1 CR2
47 lobomycosis 10.5 CD2 CR2
48 biphasic synovial sarcoma 10.5 DES MUC1 VIM
49 syringoma 10.5 DES MUC1 VIM
50 desmoplastic small round cell tumor 10.5 DES MUC1 VIM

Graphical network of the top 20 diseases related to Reticulum Cell Sarcoma:



Diseases related to Reticulum Cell Sarcoma

Symptoms & Phenotypes for Reticulum Cell Sarcoma

Symptoms via clinical synopsis from OMIM:

57
Oncology:
reticulum cell sarcoma


Clinical features from OMIM:

267730

Human phenotypes related to Reticulum Cell Sarcoma:

32
# Description HPO Frequency HPO Source Accession
1 sarcoma 32 HP:0100242

UMLS symptoms related to Reticulum Cell Sarcoma:


fatigue, fever, night sweats

MGI Mouse Phenotypes related to Reticulum Cell Sarcoma:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 9.61 ACTC1 CD4 DES FCER2 LYVE1 PTPRC
2 hematopoietic system MP:0005397 9.23 CD4 CR2 FCER2 LYVE1 PTPRC S100A9

Drugs & Therapeutics for Reticulum Cell Sarcoma

Drugs for Reticulum Cell Sarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 501)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cisplatin Approved Phase 4,Phase 3,Phase 2,Phase 1 15663-27-1 84093 441203 2767
2
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 50-18-0, 6055-19-2 2907
3
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-02-2 5743
4
Epirubicin Approved Phase 4,Phase 2 56420-45-2 41867
5
Etoposide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 33419-42-0 36462
6
Gemcitabine Approved Phase 4,Phase 3,Phase 2,Phase 1 95058-81-4 60750
7
Ifosfamide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 3778-73-2 3690
8
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 53-03-2 5865
9
Vincristine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 2068-78-2, 57-22-7 5978
10
Lenograstim Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 135968-09-1
11
Thiotepa Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 52-24-4 5453
12
Cytarabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 147-94-4 6253
13
Doxorubicin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 23214-92-8 31703
14
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1959-05-2, 59-05-2 126941
15
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83-43-2 6741
16
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-24-8 5755
17
rituximab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 174722-31-7 10201696
18
Vindesine Approved, Investigational Phase 4,Not Applicable 59917-39-4, 53643-48-4 40839
19
Mechlorethamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-75-2 4033
20
Crizotinib Approved Phase 4,Phase 2,Phase 1 877399-52-5 11626560 10366136 10366137 10366138 10366139 10366140 10366141
21
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 59-30-3 6037
22
leucovorin Approved, Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 58-05-9 143 6006
23
Doxil Approved June 1999 Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 31703
24
Pirarubicin Investigational Phase 4 72496-41-4
25 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
26 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
27 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
28 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
29 Antimitotic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
30 Antineoplastic Agents, Alkylating Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
31 Antineoplastic Agents, Hormonal Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
32 Antineoplastic Agents, Phytogenic Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
33 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
34 BB 1101 Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
35 Dexamethasone acetate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1177-87-3
36 Etoposide phosphate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
37 glucocorticoids Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
38 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
39 Hormones Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
40 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
41 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
42
Isophosphamide mustard Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 0
43 Topoisomerase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
44 Antilymphocyte Serum Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
45 Antiemetics Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
46 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
47 Antimetabolites Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
48 Antimetabolites, Antineoplastic Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
49 Antiviral Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
50 Autonomic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Interventional clinical trials:

(show top 50) (show all 880)
# Name Status NCT ID Phase Drugs
1 CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL Unknown status NCT02533700 Phase 4 CEOP/IVE/GDP chemotherapy regimen;CEOP chemotherapy regimen for 6 cycles
2 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00003398 Phase 4 cyclophosphamide;thiotepa
3 Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-grade Lymphoma in Adults Completed NCT00199082 Phase 4 Adriamycin;Cyclophosphamide;Cytarabine;Dexamethasone/Prednisolone;VP16;Ifosfamide;Methotrexate;G-CSF;Rituximab;Vincristine/Vindesine
4 Study of Brentuximab Vedotin in Patients With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma Active, not recruiting NCT01909934 Phase 4 brentuximab vedotin
5 CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma Active, not recruiting NCT01746992 Phase 4 Cyclophosphamide 750mg/m2;Vincristine 1.4mg/m2;Doxorubicin 50mg/m2;prednisone 60mg/m2;ifosfamide 2000mg/m2;pirarubicin 50mg/m2;pirarubicin 25mg/m2;Etoposide phosphate 100mg/m2;methotrexate 1500mg/m2
6 A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib Withdrawn NCT02487316 Phase 4 crizotinib
7 Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma Unknown status NCT00006455 Phase 3 cyclophosphamide;cytarabine;dexamethasone;doxorubicin hydrochloride;etoposide;ifosfamide;leucovorin calcium;methotrexate;therapeutic hydrocortisone;vinblastine sulfate
8 Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia Unknown status NCT00445497 Phase 3 amoxicillin-clavulanate potassium;ciprofloxacin
9 Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Unknown status NCT01316744 Phase 3 ketamine hydrochloride
10 Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma Unknown status NCT00052936 Phase 3 CHOP regimen;cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
11 Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia Unknown status NCT00020865 Phase 3 cefepime hydrochloride;levofloxacin
12 Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma Unknown status NCT00003815 Phase 3 carmustine;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;melphalan;prednisolone;vincristine sulfate
13 Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma Unknown status NCT00003338 Phase 2, Phase 3
14 Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma Unknown status NCT00003337 Phase 3
15 Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma Unknown status NCT00028717 Phase 3 cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
16 Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome Unknown status NCT00002989 Phase 3 busulfan;cyclophosphamide;idarubicin;melphalan
17 Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma Unknown status NCT00003423 Phase 3 asparaginase;cyclophosphamide;cytarabine;daunorubicin hydrochloride;dexamethasone;etoposide;mercaptopurine;methotrexate;prednisolone;thioguanine;vincristine sulfate
18 Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma Unknown status NCT00053768 Phase 3 EPOCH regimen;cyclophosphamide;doxorubicin hydrochloride;etoposide;prednisone;vincristine sulfate
19 High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma Unknown status NCT00003578 Phase 3 CHOP regimen;carmustine;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;melphalan;prednisone;vincristine sulfate
20 Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma Unknown status NCT00003924 Phase 3
21 Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma Completed NCT00059839 Phase 3 doxorubicin hydrochloride;mercaptopurine;methotrexate;prednisone;vinblastine sulfate;vincristine sulfate
22 Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma Completed NCT00052923 Phase 3 carmustine;cyclophosphamide;etoposide
23 Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma Completed NCT00002618 Phase 3 cytarabine;doxorubicin hydrochloride;leucovorin calcium;mercaptopurine;methotrexate;prednisone;vincristine sulfate
24 Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma Completed NCT00566228 Phase 3
25 R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma Completed NCT00144755 Phase 3 Darbepoetin alfa
26 ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1 Completed NCT00140595 Phase 3 rituximab;doxorubicin;cyclophosphamide
27 Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00012051 Phase 3 carmustine;cisplatin;cytarabine;dexamethasone;etoposide;ifosfamide;melphalan;methotrexate
28 Combination Chemotherapy With or Without Rituximab in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00064116 Phase 3 CHOP regimen
29 Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications Completed NCT00799461 Phase 3
30 Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation Completed NCT00031668 Phase 3
31 Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma Completed NCT00003595 Phase 3 CHOP regimen;cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
32 Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma Completed NCT00002649 Phase 3 cyclophosphamide;etoposide
33 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
34 American Ginseng in Treating Patients With Fatigue Caused by Cancer Completed NCT00719563 Phase 3 American ginseng
35 Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain Completed NCT00666211 Phase 3
36 Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer Completed NCT00661999 Phase 3 sodium ferric gluconate complex in sucrose
37 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
38 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Completed NCT00006348 Phase 3 ondansetron
39 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
40 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma Completed NCT00003215 Phase 3 CHOP regimen;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;leucovorin calcium;melphalan;methotrexate;methylprednisolone;mitoxantrone hydrochloride;prednisone;therapeutic hydrocortisone;vincristine sulfate
41 St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Completed NCT00005805 Phase 3
42 Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer Completed NCT00053053 Phase 3
43 Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Completed NCT00006083 Phase 3 Fragmin
44 Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00278421 Phase 3 cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
45 Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma Completed NCT00278408 Phase 3 cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
46 Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer Completed NCT00070382 Phase 3 darbepoetin alfa;epoetin alfa
47 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
48 Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma Completed NCT00005590 Phase 3 levofloxacin
49 Treatment for Chronic Pain in Patients With Advanced Cancer Completed NCT00003687 Phase 3 dextromethorphan hydrobromide;morphine sulfate
50 Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count Completed NCT00003805 Phase 3 piperacillin sodium;piperacillin-tazobactam;tazobactam sodium;vancomycin

Search NIH Clinical Center for Reticulum Cell Sarcoma

Genetic Tests for Reticulum Cell Sarcoma

Anatomical Context for Reticulum Cell Sarcoma

MalaCards organs/tissues related to Reticulum Cell Sarcoma:

41
B Cells, Bone, Bone Marrow, T Cells, Liver, Kidney, Myeloid

Publications for Reticulum Cell Sarcoma

Articles related to Reticulum Cell Sarcoma:

(show top 50) (show all 57)
# Title Authors Year
1
A Rare Case of Cytokeratin-Positive Interstitial Reticulum Cell Sarcoma and Review of the Entity. ( 27217677 )
2015
2
Cytokeratin-positive interstitial reticulum cell sarcoma: extranodal presentations mimicking carcinoma. ( 24056661 )
2013
3
Cytokeratin-positive interstitial reticulum cell sarcoma: a case report with cytological, immunohistochemical, and ultrastructural findings. ( 19207304 )
2009
4
Metastatic fibroblastic reticulum cell sarcoma of the liver: pathological and PET-CT evaluation. ( 19291544 )
2009
5
Sarcoma of follicular dendritic cells with features of sinus lining cells--a new subtype of reticulum cell sarcoma? ( 18386053 )
2008
6
Interdigitating dendritic reticulum cell sarcoma: cytologic, histologic and immunocytochemical features. ( 15945093 )
2005
7
Multifocal pigment epithelial detachments by reticulum cell sarcoma: a characteristic funduscopic picture. 1984. ( 15035397 )
2003
8
Reticulum cell sarcoma of lymph node with mixed dendritic and fibroblastic features. ( 11598178 )
2001
9
Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma: a review. ( 9766802 )
1998
10
Interdigitating reticulum-cell sarcoma of the intestine: a case report and review of the literature. ( 9285196 )
1997
11
Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362. ( 7541713 )
1995
12
A lymph node interdigitating reticulum cell sarcoma. ( 8311662 )
1994
13
True histiocytic lymphoma of small intestine. Analysis of two S-100 protein-positive cases with features of interdigitating reticulum cell sarcoma. ( 8379537 )
1993
14
Synergistic antitumor effects of carboplatin and interferons on hepatic metastases of colon carcinoma 26 and M5076 reticulum cell sarcoma. ( 8370655 )
1993
15
Antitumor activity and tissue distribution of bis(bilato)-1,2-cyclohexanediammineplatinum(II) complexes in BDF1 mice with murine reticulum cell sarcoma (M5076). ( 8330302 )
1993
16
Retroperitoneal reticulum cell sarcoma: a cause of paraneoplastic pemphigus. ( 8434295 )
1993
17
Retinal manifestations of ocular lymphoma (reticulum cell sarcoma). ( 1495797 )
1992
18
Interdigitating reticulum cell sarcoma with unusual features. ( 1799028 )
1991
19
Retinal artery obstruction and atheromas associated with non-Hodgkin's large cell lymphoma (reticulum cell sarcoma). ( 1867559 )
1991
20
Re: S. Pulciani et al., Detection of a transforming gene in spontaneous reticulum cell sarcoma of SJL/J mice: genetically linked and host-dependent neoplasia. ( 1985793 )
1991
21
Interdigitating Reticulum Cell Sarcoma Positive immunohistochemistry for HLA-DR and two other activation antigens, CD30(Ki-1) and CD25(IL2R). ( 27467676 )
1991
22
Spindle cell neoplasms of lymph nodes of probable reticulum cell lineage. True reticulum cell sarcoma? ( 2158241 )
1990
23
Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management. ( 3050698 )
1988
24
Single-gene abrogation of spontaneous pleomorphic SJL/J mouse reticulum cell sarcoma expression. ( 6353030 )
1983
25
Morphologic studies on a murine reticulum cell sarcoma (histiocytic sarcoma) of histiocytic origin and its metastases. ( 6349101 )
1983
26
Histiocytic lymphoma (reticulum-cell sarcoma) of the tongue manifesting as macroglossia. ( 6339364 )
1983
27
Reticulum cell sarcoma of the uvea. ( 7051936 )
1982
28
Characterization of a murine ovarian reticulum cell sarcoma of histiocytic origin. ( 7011532 )
1981
29
Ocular reticulum cell sarcoma. ( 7013487 )
1981
30
Ocular reticulum cell sarcoma. ( 7000173 )
1980
31
Uveitis and cerebral reticulum-cell sarcoma (large-cell lymphoma). Case report. ( 372501 )
1979
32
Clinical and radiologic remission in reticulum cell sarcoma of the brain. ( 371595 )
1979
33
Amaurosis and primary reticulum cell sarcoma of the brain: clinicopathologic study of a case. ( 343261 )
1978
34
Comparison of methyl-CCNU and CCNU in patients with advanced forms of Hodgkin's disease, lymphosarcoma nad reticulum cell sarcoma. ( 348294 )
1978
35
Intraocular reticulum cell sarcoma: its dramatic response to systemic chemotherapy and its angiogenic potential. ( 326123 )
1977
36
Primary reticulum cell sarcoma of the brain in Wiskott-Aldrich syndrome. Report of a case. ( 334130 )
1977
37
Massive spinal cord infarction due to vascular invasion by reticulum cell sarcoma. ( 769380 )
1976
38
Immuno-histological observations upon the development of reticulum cell sarcoma in the mouse. ( 775037 )
1976
39
Reticulum cell sarcoma of the cecum and macroglobulinemia: a case report. ( 817088 )
1976
40
[Rare localization of a reticulum-cell sarcoma in the clavicular epiphysis]. ( 769253 )
1976
41
Posterior uveitis and primary cerebral reticulum cell sarcoma. ( 1090291 )
1975
42
Human and experimental reticulum cell sarcoma (microglioma) of the nervous system. ( 1098366 )
1975
43
3H-thymidine autoradiography of CSF cells in primary reticulum cell sarcoma of the brain. ( 51071 )
1975
44
An inhibitor of chemotaxis and phagocytosis in reticulum cell sarcoma. ( 1101366 )
1975
45
Preliminary reticulum cell sarcoma of prostate gland. ( 1094669 )
1975
46
Chemotherapy in reticulum-cell sarcoma in five dogs and a cat and in mast-cell leukemia in a cat. ( 4936153 )
1971
47
Chronic malabsorption (steatorrhea, nontropical sprue) in an adolescent, with death from malignant lymphoma, histiocytic type (reticulum cell sarcoma). ( 4903149 )
1970
48
A case of parapsoriasis en plaques of 18 years duration terminating with Hodgkin's disease or reticulum cell sarcoma of the lymphatic tissue. ( 4884798 )
1969
49
Restrictive cardiomyopathy as the presenting feature of reticulum cell sarcoma. ( 4237284 )
1969
50
Paraproteinemia and reticulum cell sarcoma in an inbred mouse strain. ( 4886826 )
1966

Variations for Reticulum Cell Sarcoma

Expression for Reticulum Cell Sarcoma

Search GEO for disease gene expression data for Reticulum Cell Sarcoma.

Pathways for Reticulum Cell Sarcoma

GO Terms for Reticulum Cell Sarcoma

Cellular components related to Reticulum Cell Sarcoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 integral component of plasma membrane GO:0005887 9.76 CD2 CD4 CR1 FCER2 LYVE1 MUC1
2 plasma membrane GO:0005886 9.73 CD2 CD4 CR1 CR2 DES FCER2
3 external side of plasma membrane GO:0009897 9.56 CD2 CD4 FCER2 PTPRC
4 I band GO:0031674 9.37 ACTC1 S100A1
5 extracellular exosome GO:0070062 9.36 ACTC1 CR1 CR2 DES FCER2 LYVE1
6 membrane GO:0016020 10.1 ACTC1 CD2 CD4 CR1 CR2 DES

Biological processes related to Reticulum Cell Sarcoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 viral process GO:0016032 9.71 CD4 CR1 CR2 VIM
2 cytokine-mediated signaling pathway GO:0019221 9.46 CD4 FCER2 MUC1 VIM
3 cytokine production GO:0001816 9.43 CD4 S100A9
4 positive regulation of nitric-oxide synthase activity GO:0051000 9.37 FCER2 S100A1
5 astrocyte development GO:0014002 9.32 S100A9 VIM
6 intermediate filament organization GO:0045109 9.26 DES VIM
7 complement receptor mediated signaling pathway GO:0002430 8.96 CR1 CR2
8 muscle filament sliding GO:0030049 8.8 ACTC1 DES VIM

Molecular functions related to Reticulum Cell Sarcoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 signaling receptor activity GO:0038023 9.33 CD2 CD4 LYVE1
2 transmembrane signaling receptor activity GO:0004888 9.26 CD4 CR2 LYVE1 TNFRSF8
3 virus receptor activity GO:0001618 8.8 CD4 CR1 CR2

Sources for Reticulum Cell Sarcoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....